163 related articles for article (PubMed ID: 14962671)
1. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups.
Parsian A; Racette B; Zhang ZH; Rundle M; Perlmutter JS
Genomics; 2004 Mar; 83(3):454-60. PubMed ID: 14962671
[TBL] [Abstract][Full Text] [Related]
2. Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease.
Nakatome M; Tun Z; Shimada S; Honda K
Biochem Biophys Res Commun; 1998 Jun; 247(2):452-6. PubMed ID: 9642149
[TBL] [Abstract][Full Text] [Related]
3. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.
Hotamisligil GS; Girmen AS; Fink JS; Tivol E; Shalish C; Trofatter J; Baenziger J; Diamond S; Markham C; Sullivan J
Mov Disord; 1994 May; 9(3):305-10. PubMed ID: 7913737
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
5. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.
Parsian A; Sinha R; Racette B; Zhao JH; Perlmutter JS
Parkinsonism Relat Disord; 2004 Jun; 10(4):213-9. PubMed ID: 15120095
[TBL] [Abstract][Full Text] [Related]
6. Association of a monoamine oxidase B allele with Parkinson's disease.
Kurth JH; Kurth MC; Poduslo SE; Schwankhaus JD
Ann Neurol; 1993 Apr; 33(4):368-72. PubMed ID: 8489207
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
[TBL] [Abstract][Full Text] [Related]
8. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
[TBL] [Abstract][Full Text] [Related]
9. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
[TBL] [Abstract][Full Text] [Related]
10. A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
Gasser T; Müller-Myhsok B; Wszolek ZK; Oehlmann R; Calne DB; Bonifati V; Bereznai B; Fabrizio E; Vieregge P; Horstmann RD
Nat Genet; 1998 Mar; 18(3):262-5. PubMed ID: 9500549
[TBL] [Abstract][Full Text] [Related]
11. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.
Kang SJ; Scott WK; Li YJ; Hauser MA; van der Walt JM; Fujiwara K; Mayhew GM; West SG; Vance JM; Martin ER
Mov Disord; 2006 Dec; 21(12):2175-80. PubMed ID: 17044053
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population.
Morimoto Y; Murayama N; Kuwano A; Kondo I; Yamashita Y; Mizuno Y
Am J Med Genet; 1995 Dec; 60(6):570-2. PubMed ID: 8825899
[TBL] [Abstract][Full Text] [Related]
13. [The EcoR V polymorphism of human monoamine oxidase A is not associated with idiopathic Parkinson's disease in a Shanghai Han population].
Xie H; Wang X; Hao Y; Tang G; Xu L; Wu Q; Chen L; Ren D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):329-31. PubMed ID: 12170473
[TBL] [Abstract][Full Text] [Related]
14. Toward identification of susceptibility genes for sporadic Parkinson's disease.
Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
[TBL] [Abstract][Full Text] [Related]
15. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
[TBL] [Abstract][Full Text] [Related]
16. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
17. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
18. Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians.
Punia S; Das M; Behari M; Mishra BK; Sahani AK; Govindappa ST; Jayaram S; Muthane UB; K TB; Juyal RC
Pharmacogenet Genomics; 2010 Jul; 20(7):435-41. PubMed ID: 20498626
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidases A and B gene polymorphisms in migraine patients.
Filic V; Vladic A; Stefulj J; Cicin-Sain L; Balija M; Sucic Z; Jernej B
J Neurol Sci; 2005 Feb; 228(2):149-53. PubMed ID: 15694196
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
